Vimarsana
Biggest News Aggregation in the World

Page 17 - Us Regulators News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Us Regulators. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Us Regulators Today - Breaking & Trending Today

Latest Boom In Cryptocurrencies: Crypto Industry Sees Hiring Frenzy Even As Regulators Tighten Oversight - Vimarsana News

Latest Boom In Cryptocurrencies: Crypto Industry Sees Hiring Frenzy Even As Regulators Tighten Oversight

On LinkedIn, paid U.S. job postings with keywords like "cryptocurrency" and "blockchain" were up more than 600 per cent from the previous year as of August 1

Source: ndtv.com
Zoom's Five9 deal on hold as US examines China ties - Cloud - Collaboration - Vimarsana News

Zoom's Five9 deal on hold as US examines China ties - Cloud - Collaboration

The US government is looking into Zoom’s $14.7 billion acquisition of cloud contact centre software standout Five9 due to potential national-s...

Source: crn.com.au
Europian Union seeks ban on all non-essential travel to India - Vimarsana News

Europian Union seeks ban on all non-essential travel to India

Europian Union seeks ban on all non-essential travel to India Top Searches Europian Union seeks ban on all non-essential travel to India Bloomberg / May 14, 2021, 07:52 IST FacebookTwitterLinkedinEMail Representative image Boeing on Thursday said it had received approval from US regulators for a fix to an electrical problem that has grounded over 100 737 Max planes globally since April. “After gaining final approvals from the Federal Aviation Administration (FAA), we have issued service bulletins for the affected fleet,” a Boeing spokesman said. Boeing announced on April 9 that it had n...

Aspen awaits D-Day as J&J to submit vaccine trial data by 21 January - Vimarsana News

Aspen awaits D-Day as J&J to submit vaccine trial data by 21 January

Aspen awaits D-Day as J&J to submit vaccine trial data by 21 January By Antony Sguazzin (Bloomberg) – Johnson & Johnson’s preliminary data from the South African arm of a phase 3 Covid-19 vaccine trial will be ready for submission to US regulators by Jan. 21, according to the head of the country’s Medical Research Council. The timing ties in with the US drug giant’s statement that interim data from the late-stage trial it is conducting in a number of countries is expected by the end of this month. If the data show the one-dose vaccine to be safe and effective, J&J will approach US reg...